What are the next steps for a female adult patient with binge eating disorder, major depressive disorder (MDD), and generalized anxiety disorder (GAD), currently taking Zoloft (sertraline) 50mg, Trazodone 50mg, and Topamax (topiramate) 25mg, who reports some benefit from Zoloft but experiences persistent binge eating and feelings of being overwhelmed?

Management of Treatment-Resistant Binge Eating Disorder with Comorbid MDD and GAD

Increase sertraline to 200mg daily for both depression/anxiety and binge eating, and titrate topiramate to 200-400mg daily for binge eating control, as the current doses are subtherapeutic for both conditions. 1, 2, 3

Immediate Medication Adjustments

Optimize Sertraline Dosing

• Current dose of 50mg is inadequate - sertraline can be safely increased to 200mg daily for MDD and GAD 4
• For binge eating specifically, SSRIs including sertraline have demonstrated efficacy at higher doses in reducing binge frequency 2, 5
• The "somewhat working" response suggests partial benefit that warrants dose optimization rather than switching 1
• Increase by 50mg every 1-2 weeks as tolerated to reach 150-200mg daily 4

Escalate Topiramate Aggressively

• 25mg is a starting dose, not a therapeutic dose - topiramate requires 200-400mg daily for binge eating efficacy 2, 6, 3
• Topiramate has the strongest evidence for reducing both binge eating frequency AND promoting weight loss in BED 2, 6, 3
• Titrate slowly (increase by 25-50mg weekly) to minimize cognitive side effects, which are dose-dependent and can be mitigated by gradual escalation 6
• Monitor for cognitive slowing, word-finding difficulties, and paresthesias during titration 6

Trazodone Considerations

• Continue 50mg at bedtime for sleep if beneficial 1
• Trazodone showed improvement in sleep scores compared to other antidepressants in patients with depression and insomnia 1

Alternative Strategy if Optimization Fails

Consider Lisdexamfetamine

• Lisdexamfetamine is the only FDA-approved medication specifically for binge eating disorder 1, 3
• The American Psychiatric Association suggests lisdexamfetamine for adults with BED who prefer medication or have not responded to psychotherapy alone 1
• Particularly appropriate given the "overwhelmed" feelings, as it may improve executive function and impulse control 3
• Typical dosing: start 30mg daily, titrate to 50-70mg daily 3

Add or Switch to Mirtazapine

• If anxiety and feeling overwhelmed persist despite sertraline optimization, consider adding mirtazapine 7.5-30mg at bedtime 1
• Mirtazapine has faster onset of action than SSRIs and treats anxiety, depression, and insomnia simultaneously 1
• Caution: May increase appetite and promote weight gain, which could be counterproductive in BED 1

Non-Negotiable Psychotherapy Component

• Cognitive-behavioral therapy (CBT) specifically for eating disorders is the first-line treatment and should be initiated immediately 1
• The APA strongly recommends eating disorder-focused CBT for binge eating disorder (1C recommendation) 1
• Medication alone is insufficient - combination of antidepressant plus CBT is superior to either treatment alone 6
• If CBT unavailable, interpersonal therapy (IPT) is an alternative evidence-based option 1

Critical Monitoring Parameters

• Weekly weight and vital signs during medication titration 1
• Binge eating frequency (use food diary or structured assessment) 1
• Mood and anxiety symptoms using standardized scales 1
• Suicidality assessment - sertraline carries black box warning for increased suicidal thoughts in young adults during dose changes 4
• Cognitive function when escalating topiramate (word-finding, concentration, memory) 6
• Electrolytes if purging behaviors present 1

Common Pitfalls to Avoid

• Do not accept subtherapeutic dosing - both current medications are dosed too low for efficacy 4, 2
• Do not treat binge eating with antidepressants alone without concurrent eating disorder-focused psychotherapy 1, 6
• Do not use bupropion - it is contraindicated in eating disorders due to seizure risk 1, 7
• Do not abruptly discontinue sertraline if switching medications - taper over 10-14 days to avoid withdrawal syndrome 1
• Do not ignore the "overwhelmed" symptom - this suggests inadequate anxiety control requiring dose adjustment or augmentation 1

Timeline for Reassessment

• Reassess response at 6 weeks after reaching target doses 1
• If minimal response by 6 weeks, consider adding lisdexamfetamine or switching strategies 1
• Continue successful medication for at least 6-12 months after symptom remission 1